Simple blood test may spot pre-eclampsia risk early in pregnancy

NCT ID NCT01490489

Completed Diagnosis Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether a protein called EG-VEGF in the blood of pregnant women could predict pre-eclampsia or poor fetal growth. Researchers took blood samples and performed ultrasound scans on 142 women early in pregnancy. The goal was to see if EG-VEGF levels could serve as an early warning sign for these serious conditions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a simple blood test to identify pregnant women at risk for pre-eclampsia or fetal growth problems early on.
What could go wrong: This is an observational study, not a treatment trial. It only measures a potential marker; even if the marker is linked, it may not be accurate enough for routine use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRA-UTERINE GROWTH RETARDATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fetal growth restriction preeclampsia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTRA-UTERINE GROWTH RETARDATION PRE-ECLAMPSIA

Contacts and locations

Locations

Clinical investigation center of the Grenoble University Hospital

Grenoble, Isere, 38043, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.